Everything below concerns reversed-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-09-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | Linear, fifteen residues |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Approximate mass | 1419 Da | Value reported for the free peptide |
| Reported origin | Fragment of a gastric juice protein | Used as the design template |
| Common synonyms | Body protection compound 157; PL 14736 | Naming varies across papers and suppliers |
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
On 3 April 2007, The Boston Globe reported that tainted wheat gluten ended up in factories that produce food for human consumption. Then, on 19 April, federal U.S. officials said that they were investigating reports that Binzhou Futian rice protein had been used in hog feed, but declined to specify where. The California Department of Food and Agriculture placed American Hog Farm in Ceres, California under quarantine, after melamine was found in the urine of the hogs on the farm. According to California state officials, approximately 45 state residents consumed pork from hogs that had been fed melamine-contaminated feed. The FDA subsequently discovered that melamine was present in feed that had been given to hogs in California, New York, North Carolina, South Carolina, Utah, and possibly Ohio. In response, the FDA announced that, in addition to its existing practice of testing of wheat gluten and rice protein products for melamine, it would begin testing imported ingredients and finished products that contain cornmeal, corn gluten, rice bran and soy protein for the presence of melamine or cyanuric acid. The agency also subjected all vegetable proteins imported from China, intended for human or animal consumption, to detention without physical examination, beginning on 27 April. Finally, the FDA investigated domestic food manufacturers to ensure that no contaminated product was being used in foods intended for human use.
=== Phase 3 === Lysergic acid diethylamide (LSD; lysergide; MM-120; MM120) – non-selective serotonin receptor agonist and psychedelic hallucinogen [1] Ranquilon (6-phenylhexanoyl)glycyl-L-tryptophan amide; GB-115) – cholecystokinin (CCK) receptor antagonist [2] Soclenicant (BNC-210; BNC210; IW-2143; L-isoleucyl-L-tryptophan) – α7-nicotinic acetylcholine receptor negative allosteric modulator [3]
Some scientists say loxapine is a "mid-potency" typical antipsychotic. However, unlike most other typical antipsychotics, it has significant potency at the 5-HT2A receptor (6.6 nM), which is similar to atypical antipsychotics like clozapine (5.35 nM). The higher likelihood of EPS with loxapine, compared to clozapine, may be due to its higher affinity for the dopamine D2 receptor (11 nM) compared to clozapine, which has one of the lowest binding affinities at the D2 receptor of any antipsychotic. Nevertheless, its higher affinity for 5-HT2A receptors over any of the dopamine receptors (54 nM for D1, 11 nM for D2, 19 nM for D3, 8.4 nM for D4 and 75 nM) makes it belong to atypical antipsychotic. On top of being an atypical antipsychotic, Amoxapine, one of the major metabolites of Loxapine, is a tricyclic antidepressant on its own right (though sometimes classified as tetracyclic antidepressant). It acts as Serotonin–norepinephrine reuptake inhibitor, and acts as moderate and strong reuptake inhibitor for Serotonin and Norepinephrine respectively. It also share with Loxapine an high affinity for 5-HT2 receptors, (0.5 nM, and 2.0 nM for 5-HT2A and 5-HT2C receptors respectively), while having lower affinity for D2 receptors (3.6 nm), retaining Loxapine's atypical antipsychotic properties. It has also significant binding affinity for 5-HT6 and 5-HT7 receptors, and Alpha-1 adrenergic receptor.
Sources: en.wikipedia.org
On 28 September 2025, Noboa led a humanitarian convoy with UN and EU diplomats Laura Melo, Yekaterina Doródnova and Giovanni Davoli. The convoy, which was escorted by armed military, came under attack as protestors used Molotov cocktails and rocks in Cotacachi, Imbabura Province. The attack took place during nationwide strikes and protests about fuel subsidy cuts after an unarmed protestor, Efrain Fuerez, was shot dead by a soldier. It resulted in the kidnapping of 17 soldiers who were released four days later. The protests were led by the indigenous rights group Confederation of Indigenous Nationalities of Ecuador (CONAIE), who have reported repression by freezing the bank accounts of indigenous leaders and activists as well as the censorship of indigenous-led radio and TV channels. In response, Noboa declared a state of emergency in eight provinces, enforcing a curfew. On 23 October 2025, Noboa said he was the target of an assassination attempt using poisoned chocolate and jam. On 16 November 2025 a majority of Ecuadorians voted against allowing the return of foreign military bases in the country and drafting a new constitution, alongside other proposals in a referendum proposed by Noboa, being described as his first major political setback during his second term.
=== Mammalian cells === The method of detection of a field in mammalian cells is under active investigation and might involve several mechanisms. For now, it is thought that redistribution of membrane-bound sensors dragged by Coulombic forces and electro-osmosis at the membrane would cause the cell to polarize, then migrate. Mathematical modeling suggests that a 6-10% change in sensor concentration across the cell is detectable. Experiments that repeatedly changed orientation of a field applied to several cell lines suggest that sensor polarization occurs on a relatively rapid timescale, perhaps several seconds, compared to the cell migration response, which is observed after 5–10 minutes. This allows cells to time-average changes in the direction of the electric field before migrating.
=== Synthesis and release === Oxcytocin is linked to the process of childbirth and milk ejection reflex. Oxytocin is produced in the brain and several reproductive tissues during pregnancy, while the receptors are produced in reproductive tissues. During human parturition, the quantifiable level of blood plasma oxytocin rises: it becomes twice as much during the initial phase of dilation and continues to increase until the second stage of labor. Oxytocin furthermore induces uterine contractions in mothers following childbirth which helps in the prevention of bleeding.
=== Fermentation === Possibly the world's oldest fermented beverage, dating from 9,000 years ago, mead ("honey wine") is the alcoholic product made by adding yeast to honey-water must and fermenting it for weeks or months. The yeast Saccharomyces cerevisiae is commonly used in modern mead production. Mead varieties include drinks called metheglin (with spices or herbs), melomel (with fruit juices, such as grape, specifically called pyment), hippocras (with cinnamon), and sack mead (high concentration of honey), many of which have been developed as commercial products numbering in the hundreds in the United States. Honey is also used to make mead beer, called "braggot".
Sources: en.wikipedia.org
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.
The sequence corresponds to a segment of a naturally occurring gastric protein, so related sequence material exists in the body. The peptide itself as sold and studied is a laboratory-synthesized product. Whether an identical free peptide circulates naturally is not established.
No major regulatory agency has approved it as a medicine for any indication. It appears in research supply channels and, in some jurisdictions, in compounded preparations. Clinical use therefore sits outside standard approved-product pathways, and regulatory status varies by country.
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.